Cargando…
Combined treatment with dipeptidyl peptidase 4 (DPP4) inhibitor sitagliptin and elemental diets reduced indomethacin-induced intestinal injury in rats via the increase of mucosal glucagon-like peptide-2 concentration
The gut incretin glucagon-like peptide-1 (GLP-1) and the intestinotropic hormone GLP-2 are released from enteroendocrine L cells in response to ingested nutrients. Treatment with an exogenous GLP-2 analogue increases intestinal villous mass and prevents intestinal injury. Since GLP-2 is rapidly degr...
Autores principales: | Fujiwara, Kaori, Inoue, Takuya, Yorifuji, Naoki, Iguchi, Munetaka, Sakanaka, Taisuke, Narabayashi, Ken, Kakimoto, Kazuki, Nouda, Sadaharu, Okada, Toshihiko, Ishida, Kumi, Abe, Yosuke, Masuda, Daisuke, Takeuchi, Toshihisa, Fukunishi, Shinya, Umegaki, Eiji, Akiba, Yasutada, Kaunitz, Jonathan D., Higuchi, Kazuhide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
the Society for Free Radical Research Japan
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345177/ https://www.ncbi.nlm.nih.gov/pubmed/25759522 http://dx.doi.org/10.3164/jcbn.14-111 |
Ejemplares similares
-
Preventive effect of irsogladine or omeprazole on non-steroidal anti-inflammatory drug-induced esophagitis, peptic ulcers, and small intestinal lesions in humans, a prospective randomized controlled study
por: Kuramoto, Takanori, et al.
Publicado: (2013) -
Effect of long-term proton pump inhibitor therapy and healing effect of irsogladine on nonsteroidal anti-inflammatory drug-induced small-intestinal lesions in healthy volunteers
por: Kojima, Yuichi, et al.
Publicado: (2015) -
Effect of egualen sodium hydrate on small-intestinal mucosal damage induced by low-dose aspirin: a prospective randomized clinical trial
por: Iguchi, Munetaka, et al.
Publicado: (2018) -
Dipeptidyl peptidase-4 (DPP-4; CD26)
Publicado: (2013) -
A comparative study of the binding properties, dipeptidyl peptidase‐4 (DPP‐4) inhibitory activity and glucose‐lowering efficacy of the DPP‐4 inhibitors alogliptin, linagliptin, saxagliptin, sitagliptin and vildagliptin in mice
por: Berger, Joel P., et al.
Publicado: (2017)